Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including advanced cardiac care, orthopaedics, oncology, renal sciences, neurosciences, minimal access metabolic and bariatric surgery, obstetrics, gynaecology, paediatrics, nephrology, and general surgery, as well as liver, heart, kidney, lung and bone marrow transplants. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.

Revenue projections:

Revenue projections for MAXHEALTH
Revenue projections for MAXHEALTH

Max Healthcare Institute Limited's revenue is forecasted to dip below last year's figures, raising concerns for investors who are typically wary of declining financial performance. Such drops can directly affect the company's bottom line, potentially leading to a decrease in overall profitability, making investors more cautious in their decisions.

Financial Ratios:

currentRatio 0.79300
forwardPE 44.23476
debtToEquity 32.57900
earningsGrowth 0.74300
revenueGrowth 0.25100
grossMargins 0.62122
operatingMargins 0.21871
trailingEps 13.88000
forwardEps 22.41224

With positive growth in both earnings and revenue, Max Healthcare Institute Limited is expected to grow its business. These indicators highlight a strong financial outlook, with the company on track for continued expansion and increasing profitability.
MAXHEALTH's positive gross and operating margins reflect strong profitability and operational efficiency. These metrics indicate the company's ability to control costs while maintaining healthy revenue, contributing to its solid financial performance.
MAXHEALTH's forward EPS is higher than its trailing EPS, suggesting the company is expected to improve its profitability this financial year. This reflects growing confidence in MAXHEALTH's earnings potential, with forecasts indicating better financial performance than in the prior year.

Price projections:

Price projections for MAXHEALTH
Price projections for MAXHEALTH

The steady upward revision of MAXHEALTH's price projections indicates growing confidence in the company's performance. Analysts are becoming increasingly optimistic about MAXHEALTH's future prospects and potential for growth.

Recommendation changes over time:

Recommendations trend for MAXHEALTH
Recommendations trend for MAXHEALTH


With analysts showing a buy bias for MAXHEALTH, investors may be more inclined to see the stock as an attractive investment. The favorable outlook could spur increased interest, positioning MAXHEALTH as a safe and profitable place for investors to allocate their funds and seek growth.